CEACAM5 and intrahepatic cholangiocarcinoma: As shown in Table 2, ICC patients with an FGFR2 fusion/rearrangement presented with low levels of carcinoembryonic antigen (CEA, P = .026), gamma glutamyl transferase (γ-GGT, P = .003), and low CNCL/TNM staging.